Leukemic stem cells in childhood high-risk ALL/t(9;22) and t(4;11) are present in primitive lymphoid-restricted CD34+CD19- cells.
about
Ph+/VE-cadherin+ identifies a stem cell like population of acute lymphoblastic leukemia sustained by bone marrow niche cellsRevisiting the biology of infant t(4;11)/MLL-AF4+ B-cell acute lymphoblastic leukemiaStem Cell Hierarchy and Clonal Evolution in Acute Lymphoblastic LeukemiaTargeted Cancer Therapy: Vital Oncogenes and a New Molecular Genetic Paradigm for Cancer Initiation Progression and TreatmentSelf-renewal of acute lymphocytic leukemia cells is limited by the Hedgehog pathway inhibitors cyclopamine and IPI-926Chimeric antigen receptor-modified T cells for acute lymphoid leukemiaDifferentiation of naive cord-blood T cells into CD19-specific cytolytic effectors for posttransplantation adoptive immunotherapy.Combining CD19 redirection and alloanergization to generate tumor-specific human T cells for allogeneic cell therapy of B-cell malignancies.Cancer stem cells: controversies in multiple myelomaLack of expression of the chondroitin sulphate proteoglycan neuron-glial antigen 2 on candidate stem cell populations in paediatric acute myeloid leukaemia/abn(11q23) and acute lymphoblastic leukaemia/t(4;11).High frequencies of leukemia stem cells in poor-outcome childhood precursor-B acute lymphoblastic leukemias.Clonal origins of ETV6-RUNX1⁺ acute lymphoblastic leukemia: studies in monozygotic twins.Ink4a and Arf are crucial factors in the determination of the cell of origin and the therapeutic sensitivity of Myc-induced mouse lymphoid tumor.Cancer Stem Cells: From Bench to BedsidePrecursor B-acute lymphoblastic leukemia occurring in patients with a history of prior malignancies: is it therapy-related?Towards targeted therapy for infant acute lymphoblastic leukaemia.Bryostatin-1, Fenretinide and 1α,25 (OH)(2)D(3) Induce Growth Inhibition, Apoptosis and Differentiation in T and B Cell-Derived Acute Lymphoblastic Leukemia Cell Lines (CCRF-CEM and Nalm-6)Acute leukemia in early childhood.Induction of acute lymphocytic leukemia differentiation by maintenance therapyMolecular targeting of MLL-rearranged leukemia cell lines with the synthetic peptide PFWT synergistically enhances the cytotoxic effect of established chemotherapeutic agents.Leukemia stem cells and human acute lymphoblastic leukemia.Etoposide-initiated MLL rearrangements detected at high frequency in human primitive hematopoietic stem cells with in vitro and in vivo long-term repopulating potential.A case of minor BCR-ABL1 positive acute lymphoblastic leukemia following essential thrombocythemia and originating from a clone distinct from that harboring the JAK2-V617F mutation.Understanding the cancer stem cell.Insights into the cellular origin and etiology of the infant pro-B acute lymphoblastic leukemia with MLL-AF4 rearrangement.Chromosomal translocations among the healthy human population: implications in oncogenesis.Philadelphia chromosome-positive leukemia stem cells in acute lymphoblastic leukemia and tyrosine kinase inhibitor therapy.Genetically engineered mouse models of human B-cell precursor leukemias.Role of Pericellular Matrix in the Regulation of Cancer Stemness.Characterization of mammary cancer stem cells in the MMTV-PyMT mouse model.In childhood acute lymphoblastic leukemia, blasts at different stages of immunophenotypic maturation have stem cell properties.Acute B lymphoblastic leukaemia-propagating cells are present at high frequency in diverse lymphoblast populations.Human chromosomal translocations at CpG sites and a theoretical basis for their lineage and stage specificity.Initial frequency of CD34+/CD38 - cells is not correlated with minimal residual disease level in 73 Chinese children with B-cell precursor acute lymphoblastic leukemia.Leukemia stem cells.NG2 antigen is involved in leukemia invasiveness and central nervous system infiltration in MLL-rearranged infant B-ALL.Molecular processes involved in B cell acute lymphoblastic leukaemia.Leukemia stem cells.Analysis of genomic breakpoints in p190 and p210 BCR–ABL indicate distinct mechanisms of formation
P2860
Q24650730-5A54482D-C0A6-458C-973F-5CE279044CB4Q26783577-1507CBCF-2CB7-4C53-99F5-0D0CF9DF5840Q26799954-EB6BC24C-E15D-43D2-965C-FF14F28A46AFQ28076462-E536114F-DC3D-4461-8543-68C8C98B064BQ28743931-53433EF9-D613-4E5C-8C25-12DF3357E94AQ29620130-590E4B46-842D-43C8-A8AC-24A4FB1CA5D1Q30479628-9D7BA187-6311-420E-A15B-0B32B63EFE3EQ33862876-49A6BAC4-2BDF-45FA-BABE-9BAC95116708Q34462722-3BDCC96B-6E83-4E89-A17C-47D8C87257F0Q34518408-5626FFE5-E782-4166-A117-2E56F46B1882Q34562163-8C0F744C-0D12-4329-934C-22F29F4AF4B7Q35411913-701AE5CB-1537-42A1-863B-836B46D9C034Q35729943-DF42A1B1-4BC6-4B69-B48F-02F9751A6E99Q35765724-7D9EE467-D43D-4F38-87F1-22BCAA8B0F4FQ36006426-999A5663-BE56-4B19-ACCF-61D2747ECAD9Q36381561-9C513722-00EB-476A-946B-72C5F61D1341Q36571416-E0E516F1-FA62-464B-BE8C-750DEAD423DBQ36854329-23160C89-AE00-41B4-A9DD-E27B0FC8AA16Q37098221-82F82EE7-6850-4B00-BCCA-C0BA71A8CC8CQ37260555-E446DB2C-7238-43D2-ACFD-A9452B7C1ED9Q37355972-7E47566E-AF53-4A24-97D2-8A9F8EEEA305Q37463163-EFA9658A-AEBC-4502-AAFF-2C631D1A463DQ37600070-DB4AE098-ABFE-4D40-A6C7-822AC4C23D15Q37776152-880B5231-72A6-42E3-8437-F61FC182B162Q37816933-793CD72E-03A5-42EB-BF4A-5DEBEE9D3529Q38040618-D3835883-ADAC-4AB5-89A5-55D069C0FB16Q38044901-EDB5EDB3-E2EF-474E-869A-EBADF0DF59E0Q38285177-523E11CF-9E6E-4898-82B6-997F6C3C3BCCQ38770102-7FED1638-7C5E-4DEC-A496-DA85E52E99ECQ39299986-A840C57A-F40C-4111-89F2-15A136D99CD6Q39965610-048DC6FB-3D86-4080-90D7-A6B0EA78AAFBQ41813318-ED200F7F-7411-4CDB-B01F-7F802BB75557Q42260473-16DF66CC-0BE1-497F-9E72-819E6DE692C0Q45351191-2F38E5DF-0027-49AB-AD2E-DF618AE67062Q46509360-A39AF635-5726-4BD5-864B-C7DE70EEE79FQ47930875-46F50C42-D066-4054-A91E-F6CF3B418E7BQ48218289-D1C43CAD-E2B0-418F-86E4-49B1AF0E12EBQ53293069-57A0B41E-4D45-4187-BB75-1EA3CA11CE45Q58455677-BFC226D0-BB37-4C2D-81FF-E62114885844
P2860
Leukemic stem cells in childhood high-risk ALL/t(9;22) and t(4;11) are present in primitive lymphoid-restricted CD34+CD19- cells.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Leukemic stem cells in childhood high-risk ALL/t
@nl
Leukemic stem cells in childho ...... d-restricted CD34+CD19- cells.
@en
type
label
Leukemic stem cells in childhood high-risk ALL/t
@nl
Leukemic stem cells in childho ...... d-restricted CD34+CD19- cells.
@en
prefLabel
Leukemic stem cells in childhood high-risk ALL/t
@nl
Leukemic stem cells in childho ...... d-restricted CD34+CD19- cells.
@en
P2093
P1433
P1476
Leukemic stem cells in childho ...... d-restricted CD34+CD19- cells.
@en
P2093
André Schrauder
Annegret Rosemann
Heribert Jürgens
Jochen Harbott
Josef Vormoor
Marc Hotfilder
Silja Röttgers
P304
P356
10.1158/0008-5472.CAN-04-1356
P407
P577
2005-02-01T00:00:00Z